The Imperial College London Diabetes Centre (ICLDC), part of the M42 group, has announced it will open a dedicated one-stop facility in Madinat Zayed to provide comprehensive care for diabetes and endocrine patients.
The new tech-enabled, world-class center in Al Dhafra will serve a critical part of Abu Dhabi’s population, providing targeted prevention and intervention for more than 6,000 diabetes sufferers in the region.
Set to open in the second half of this year, the state-of-the-art facility will bring comprehensive care closer to those in need and cut travel time by more than 75 percent.
Currently, the flagship ICLDC in Abu Dhabi city serves around 9 percent of the Al Dhafra population of sufferers. The new facility in Madinat Zayed will provide greater access to sufferers across the Al Dhafra region including residents in Liwa, Mirfa, Gayathi, Ruwais, and Tarif.
Hasan Jasem Al Nowais Group CEO & MD M42
“M42 is committed to providing world-class preventive and personalized health solutions that enable individuals to put their health back in their own hands. As a leader in diabetes and endocrine management and prevention, the Imperial College London Diabetes Centre is positively impacting lives across the UAE. Expanding our one-stop services to Al Dhafra presents an opportunity to serve a much greater number of UAE residents with an innovative model that provides premium, tech-enabled health solutions that result in tangible positive clinical outcomes.”
In addition to providing clinical care, ICLDC will continue to promote preventive solutions for Type 2 diabetes, with an extensive community outreach program including workshops, health screenings, and educational programs for schools and organizations, as well as promoting an active lifestyle and healthy eating.
The new Al Dhafrah ICLDC center will be equipped with the latest diagnostic and management facilities supported by a world-class multi-specialty team. The center will operate state-of-the-art outpatient services, providing specialized care for diabetes and endocrine-related complications.
Dr. Mai Al Jaber, Chief Executive Officer of ICLDC, said that, “Today, the need for accessible and comprehensive diabetes care has never been more apparent. Serving more of the Al Dhafra population is an honor and a duty we are fully committed to. Our aim is to provide patients with the best patient-centric and comprehensive diabetes and endocrinology solutions, under one roof and closer to home.”
